Health insurance accessibility. Artificial Intelligence in health care.
2026 · 3rd Quarter (July 1 - Sep 30)
ELI LILLY AND COMPANY
Filed by TODD STRATEGY GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- $80,000.00
- Expenses
- Not reported
- Registrant
- TODD STRATEGY GROUP
- Client
- ELI LILLY AND COMPANY
- Filing UUID
- f44b3137-aec1-41dc-b591-d1a88ed8357b
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Medicare & Medicaid prescription drug diagnosis and screening reimbursement pricing, coverage, value and access. CMS National Coverage Determination on Alzheimer's disease. Implementation of the Inflation Reduction Act.
Drug pricing, coverage, value, access and quality. Prescription drug approval. Drug importation. 340 B. Intellectual property. Pharmaceutical supply chain issues and shortages. Transparency. Issues related to intellectual property protection and market access within current trade negotiations.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.